Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects
Clinical trial NCT03327558 · COMPLETED
Trial details
- NCT number
- NCT03327558
- Sponsor
- Bausch Health Americas, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-15
- Primary completion
- 2017-06-23
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.